sika_mainlogo.jpg
Wechsel in der Leitung Finanzen und Controlling
August 08, 2001 12:43 ET | Sika AG
For release content, please refer to the attachment....
sika_mainlogo.jpg
Sika Group - changes at the top of Finance and Controlling
August 08, 2001 12:35 ET | Sika AG
For release content, please refer to the attachment....
sika_mainlogo.jpg
Sika Konzern - Wechsel in der Leitung Finanzen und Controlling
August 08, 2001 12:33 ET | Sika AG
For release content, please refer to the attachment....
sika_mainlogo.jpg
Sika Group - changes at the top of Finance and Controlling
August 08, 2001 12:24 ET | Sika AG
For release content, please refer to the attachment....
sika_mainlogo.jpg
Sika Konzern - Wechsel in der Leitung Finanzen und Controlling
August 08, 2001 12:20 ET | Sika AG
For release content, please refer to the attachment....
Osprey Energy: Northern Louisiana Sale Generates $1.8 Million and Three Wells
August 08, 2001 11:56 ET | Osprey Energy
BRIDGEWATER, Nova Scotia, Aug. 8, 2001 (PRIMEZONE) -- Osprey Energy (CDNX:OEL) is pleased to announce the signing of a letter of intent with one of the world's largest natural gas producers, to sell...
Schibsted_Logotype_L1_Dust-black_RGB-300x54.png
Meldepliktig handel
August 08, 2001 11:16 ET | Schibsted
Ansatte i Schibsted konsernet har i år, som tidligere år, fått tilbud om å kjøpe aksjer i Schibsted ASA for inntil NOK 6.000 til en rabattert kurs. Kursen ble fastsatt til gjennomsnittlig markedspris...
Schibsted_Logotype_L1_Dust-black_RGB-300x54.png
Purchase of shares by primary insiders
August 08, 2001 11:15 ET | Schibsted
As in previous years, employees in the Schibsted Group have been given rights to purchase shares for an amount of NOK 6,000.- at a 20% discounted price. The share price of NOK 77.80 per share (20%...
Active Biotech Delår
Active Biotech Delårsrapport januari-juni
August 08, 2001 09:57 ET | Active Biotech
Active Biotech koncentrerar på läkemedelsutveckling Försäljning av SBL Vaccin genomförd, reavinst i koncernen 190 Mkr (moderbolaget 150 Mkr). Kassan ökar med drygt en halv miljard kronor Framgångar...
Active Biotech AB, D
Active Biotech AB, Delårsrapport januari - juni
August 08, 2001 09:45 ET | Active Biotech
Active Biotech koncentrerar på läkemedelsutveckling Försäljning av SBL Vaccin genomförd, reavinst i koncernen 190 Mkr (moderbolaget 150 Mkr). Kassan ökar med drygt en halv miljard kronor Framgångar...